Evgen
Latest round
- Series A
Last raised
- Aug 2011
Total raised
- $1.9M
Investors
- 2
About Evgen
Evgen specializes in therapeutics for behavioral brain disorders, with a presence in Liverpool, UK. Founded by individuals with prior experience in the field, the company completed an IPO in October 2015.Evgen develops innovative therapeutics targeting behavioral brain disorders, focusing on three primary drug candidates: Ox-1, which addresses addictive behaviors and anxiety; DAT, aimed at alleviating central fatigue; and SFX-01, which targets glioblastoma tumors.60.Evgen is focused on advancing its drug candidates Ox-1, DAT, and SFX-01 through clinical trials, with a strategic emphasis on launching these products in North America and Europe by specific dates yet to be disclosed.
Who invested in Evgen
2 investors across 1 round
See all investors in Evgen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 25, 2011
Amount
$1.9M
Investors
Questions about Evgen
Who invested in Evgen?
Evgen has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evgen raised?
Evgen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Evgen last raise money?
Evgen's most recent round on record is a Series A, in Aug 2011.
What does Evgen do?
Evgen specializes in therapeutics for behavioral brain disorders, with a presence in Liverpool, UK.
Where is Evgen headquartered?
Evgen is headquartered in Liverpool, UK.
Which VCs invest in companies like Evgen?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Evgen's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Evgen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.